Shyama Computronics and Services Limited

BSE: SHYAMACOMP · Pharmaceuticals

—
52W Range₹2 – ₹6

Limited coverage

We are not actively covering this company or have limited coverage today. Click to request coverage.

Snapshot

Unlock Shyama Computronics and Services Limited's vital signs

Growth · Profitability · Valuation · Strength · Conviction

Company Overview

Business

Shyama Computronics and Services Limited is an Indian company based in Kolkata that operates as a multi-brand retailer and distributor of computer hardware, peripherals, and consumer electronics. The firm also provides IT support services and maintenance solutions to both retail and corporate clients.

Business Model

The company generates revenue through the procurement and sale of IT hardware and consumer electronics, supplemented by income from technical support and maintenance services.

Growth Outlook

Growth is driven by the increasing demand for digital infrastructure within the eastern region of India, supported by the company's established distribution network.

Key Risks

  • Market Competition. The retail and distribution sector for electronics is highly competitive, which may exert pressure on profit margins.
  • Geographic Concentration. The company's heavy reliance on the West Bengal market exposes it to regional economic fluctuations.
  • Supply Chain Dependency. As a distributor of global brands, the company is vulnerable to disruptions in the supply chain and changes in vendor policies.
  • Liquidity Risk. As a micro-cap entity listed on the BSE SME platform, the company may face challenges related to low trading volumes and capital accessibility.

Start your research today

Unlock AI insights, financials, peers and live data on Shyama Computronics and Services Limited and 5,000+ companies — free.

Start your research

Peers · Pharmaceuticals

CompanyMkt CapP/EEV/EBITDARev Gr YoYEBITDA MgnROEROCE1Y Return
Shyama Computronics and Services LimitedSHYAMACOMP
₹4 Cr———17.9%———
TranschemTRANSCHEM
₹502 Cr75.6252.99-100.0%177.7%8.3%10.6%+600.8%
Albert DavidALBERTDAVD
₹501 Cr21.6713.1911.4%11.0%5.8%7.5%+10.3%
Haleos Labs LimitedHALEOSLABS
₹457 Cr28.5112.83-3.1%13.6%7.4%10.3%—
Medicamen BiotecMEDICAMEQ
₹434 Cr43.0019.7624.7%11.3%4.1%6.2%+5.9%
Jenburkt Pharmaceuticals LimitedJENBURPH
₹420 Cr12.308.20—30.0%16.7%21.5%-15.2%

As of Mar 2026

Financials